# Nepal Undifferentiated Febrile Illness Trial

> **NCT02773407** · PHASE3 · COMPLETED · sponsor: **Oxford University Clinical Research Unit, Vietnam** · enrollment: 330 (actual)

## Conditions studied

- Undifferentiated Febrile Illness

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Co-trimoxazole

## Key facts

- **NCT ID:** NCT02773407
- **Lead sponsor:** Oxford University Clinical Research Unit, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-23
- **Primary completion:** 2019-08-04
- **Final completion:** 2019-08-04
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02773407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02773407, "Nepal Undifferentiated Febrile Illness Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02773407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*